was initially included for the support and application of imaging of animal models of cancer. The resource is provided by the Vanderbilt University Institute of Imaging Science (VUIIS), a trans-institutional program established in 2002 that brings together a diverse and expert group of imaging scientists dedicated to the development and application of advanced imaging techniques in biomedical research. Over the past five years, the Cancer Center has been the major user of animal imaging, and cancer applications dominate usage of the imaging facilities. For example, in the past year, over 25 different principal investigators from the Vanderbilt-lngram Cancer Center (VICC) have used the resource, engaging the staff and equipment on more than 50 different projects/studies. In total, these studies used 4,650 hours of high-field MRI and MRS, nuclear imaging (PET, SPECT, and CT), optical imaging, and ultrasound. Today the resource is a very active component of the CCSG. This renewal seeks support for a major expansion to include human research imaging. In particular, we will provide organizational, administrative and financial support to encourage stronger and more formal collaborations between radiologists, imaging scientists and clinical oncologists working as teams engaged in the evaluation of clinical trials. We will also work with VICC investigators to identify appropriate imaging biomarkers and implement quantitative imaging methods that can be used as surrogate measures for clinical outcomes and that may be incorporated into clinical trials of novel anticancer agents. Thus, the aims of the Imaging Resource are to enable VICC investigators to: 1. Execute quantitative in vivo imaging studies in models of cancer, 2. Apply and validate MRI, optical, CT, PET, SPECT, and ultrasound methods for the noninvasive detection and characterization of treatment response in small animals; 3. Incorporate emerging, and clinically relevant, quantitative MRI and PET protocols into appropriate Phase I, II, and 111 clinical trials established at VICC. A fundamental strength of this shared resource is that the imaging science expertise obtained in preclinical studies with leading cancer scientists and physicians can be directly translated into, and inform, clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-18
Application #
8733536
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
18
Fiscal Year
2014
Total Cost
$320,357
Indirect Cost
$89,304
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A et al. (2018) Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 49:363-374.e10
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Means, Anna L; Freeman, Tanner J; Zhu, Jing et al. (2018) Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 6:257-276
Du, Zhenfang; Lovly, Christine M (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58
Zhang, Qin; Jeppesen, Dennis K; Higginbotham, James N et al. (2018) Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cell Mol Gastroenterol Hepatol 5:627-629.e6
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255

Showing the most recent 10 out of 2462 publications